Wai Yuen Tong Medicine Holdings Limited provided earnings guidance for the financial year ended 31 March 2023. For the period, the company expected to record a loss attributable to owners of the parent of not more than HKD 35 million for the financial year ended 31 March 2023 as compared with a loss attributable to owners of the parent for the financial year ended 31 March 2022 of approximately HKD 108.9 million as published in the Company's 2022 annual report.